Estrogen could be viable treatment option for Parkinson's patients

Brain-selective estrogen treatment improves the symptoms of Parkinson’s disease in male mice, according to new research published in JNeurosci. These findings may help explain the sex differences in Parkinson’s disease and could lead to estrogen-based treatments.

Estrogen could be viable treatment option for Parkinson

Parkinson’s disease is characterized by the death of neurons involved in movement, which may be partially caused by gene mutations for the protein α-synuclein. The mutated, shorter form of the protein clusters in neurons, resulting in their death, while the longer form resists clumping.

Estrogen is thought to protect movement neurons from Parkinson’s disease, but how is unknown. Since the patients more susceptible to Parkinson’s disease — men and post-menopausal women — have low estrogen levels, estrogen treatment might be an effective way to delay and reduce symptoms.

Silke Nuber and colleagues at Harvard Medical School treated mouse models of Parkinson’s disease with brain-selective estrogen and compared the motor performance of males and females before and after treatment. The female mice showed less severe symptoms at a later age, but estrogen still improved their symptoms. In male mice, the estrogen treatment reduced α-synuclein breakdown and buildup and helped with severe symptoms, suggesting that estrogen could be a viable treatment option for Parkinson’s patients with low estrogen levels.

Source:
Journal reference:

Rajsombath, M.M. et al. (2019) Female sex and brain-selective estrogen benefit α-synuclein tetramerization and the PD-like motor syndrome in 3K transgenic mice. Journal of Neuroscience. doi.org/10.1523/JNEUROSCI.0313-19.2019.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Society for Neuroscience. (2019, August 13). Estrogen could be viable treatment option for Parkinson's patients. News-Medical. Retrieved on September 22, 2019 from https://www.news-medical.net/news/20190813/Estrogen-could-be-viable-treatment-option-for-Parkinsons-patients.aspx.

  • MLA

    Society for Neuroscience. "Estrogen could be viable treatment option for Parkinson's patients". News-Medical. 22 September 2019. <https://www.news-medical.net/news/20190813/Estrogen-could-be-viable-treatment-option-for-Parkinsons-patients.aspx>.

  • Chicago

    Society for Neuroscience. "Estrogen could be viable treatment option for Parkinson's patients". News-Medical. https://www.news-medical.net/news/20190813/Estrogen-could-be-viable-treatment-option-for-Parkinsons-patients.aspx. (accessed September 22, 2019).

  • Harvard

    Society for Neuroscience. 2019. Estrogen could be viable treatment option for Parkinson's patients. News-Medical, viewed 22 September 2019, https://www.news-medical.net/news/20190813/Estrogen-could-be-viable-treatment-option-for-Parkinsons-patients.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Social and executive brain functions critical for effective communication